Guzip Biomarkers Corporation
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
Guzip’s flagship products include MPap® and RitaPap®, both of which use methylation-specific qPCR to detect methylation status of key genes; MPap uses cervical scrape samples, while RitaPap uses tampon-collected samples.
They also develop a MUrine test (
They also develop a MUrine test (
Founded Year
2018
Unified Business No.
50859246
Status
Active
Number of Employees
10
Total Paid-in
Capital
38,723,910 (NT$)
Location of Company
Taiwan
, Hsinchu County
Exit Status
Acquired(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Guzip Biomarkers Corporation, founded in 2018 as a spin‑out from Taipei Medical University, is a research‑driven biotech company specializing in epigenetics and DNA methylation.
Their mission is to develop novel methylation‑based biomarkers for clinical
Their mission is to develop novel methylation‑based biomarkers for clinical
Corporate Video
